HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of early intervention with inhaled sodium cromoglycate in childhood asthma.

Abstract
International and Japanese guidelines classify childhood asthma as mild, moderate, or severe, and recommend treatment with "as needed" bronchodilators, inhaled sodium cromoglycate, and inhaled corticosteroids, respectively. Alternatively, some investigators proposed inhaled corticosteroids as first-line therapy to prevent airway inflammatory obstruction. This article describes a clinical study assessing the effect of early intervention with inhaled sodium cromoglycate in childhood asthma. This was a retrospective study of 189 asthmatic children treated with inhaled sodium cromoglycate for five years and whose age of onset of asthma was six year of age or younger. An end-of-study questionnaire completed the examination. Children administered oral or inhaled corticosteroids simultaneously with sodium cromoglycate, were excluded. Asthma scores as defined by the Japanese Pediatric Allergic Committee, were reduced continuously during the five years after the start of sodium cromoglycate treatment. The frequency of emergency department visits and hospitalizations also decreased. Significant between-period intervention differences showed improvement of clinical outcomes for children with severe asthma during the five years of sodium cromoglycate inhalation. The early intervention regime of starting sodium cromoglycate inhalation within two years of the onset of asthma shows a large improvement in the long-term prognosis of childhood asthma, especially for children with severe asthma. It is possible that starting inhaled sodium cromoglycate earlier than the present recommendation of corticosteroids could further improve clinical outcomes, but a prospective study should be performed to verify our results.
AuthorsS Yoshihara, N Kanno, Y Yamada, M Ono, N Fukuda, M Numata, T Abe, O Arisaka
JournalLung (Lung) 2006 Mar-Apr Vol. 184 Issue 2 Pg. 63-72 ISSN: 0341-2040 [Print] United States
PMID16622775 (Publication Type: Journal Article)
Chemical References
  • Anti-Asthmatic Agents
  • Glucocorticoids
  • Cromolyn Sodium
Topics
  • Administration, Inhalation
  • Anti-Asthmatic Agents (administration & dosage, therapeutic use)
  • Asthma (drug therapy)
  • Cromolyn Sodium (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Infant
  • Male
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: